ArticleBritish journal of cancer2014
50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence.
Article in British journal of cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
110 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.BMC cancer · 2023Pooled it
- New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.European journal of epidemiology · 2018Pooled it
- Increasing coverage in cervical and colorectal cancer screening by leveraging attendance at breast cancer screening: A cluster-randomised, crossover trial.PLoS medicine · 2024Trial
- How does information on the harms and benefits of cervical cancer screening alter the intention to be screened?: a randomized survey of Norwegian women.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2019Trial
- Trial
- Trial
- Trial
- Long-Term Regional Pathology-Detection Trends in High-Grade Cervical Lesions and Cervical Squamous Cell Carcinoma Among Women Aged 40-69 Years in Northern Norway, 1998-2025.Diagnostics (Basel, Switzerland) · 2026Article
- Human Papilloma Virus (HPV) prevalence and genotype distribution among women in Karachi, Pakistan.Journal of virus eradication · 2026Article
- Trends in the incidence of cancers of the breast and female genital tract in Harare, Zimbabwe 1990-2019.International journal of cancer · 2026Article
- Educational inequalities in cervical cancer mortality in the Baltic countries and Finland in the context of organized screening: A register-based study 2000-2015.International journal of cancer · 2026Article
- Indicators to identify cancer screening providers with suboptimal case detection: A scoping review.International journal of cancer · 2026Article
- Article
- Redefining Cytotechnologist Practice in Sweden: National Survey on Workload, Expanded Roles, and Future Competency Needs.Acta cytologica · 2026Article
- Transgender Men's and Non-Binary People's Experiences of Cervical Cancer Screening-A Journey Mapping Approach.Journal of clinical nursing · 2026Article
- Women's compliance with cervical cancer screening recommendations and associated barriers to participation: A cross-sectional analysis.PloS one · 2026Article
- Beyond Women's Health: Long-Term Human Papillomavirus-Related Cancer Trends in Norway.The Journal of infectious diseases · 2025Observational
- Communicating abnormal cervical cancer screening results - a focus group study with general practitioners in Norway.Scandinavian journal of primary health care · 2025Article
- Emerging trends in cervical cancer incidence among younger Taiwanese generations: an urban-rural comparison.Annals of medicine · 2025Article
- Predicting Pre- and Post-Diagnostic Depression in Women with Abnormal Pap Screening Tests: A Neural Network Approach.Life (Basel, Switzerland) · 2025Article
50 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundNordic countries' data offer a unique possibility to evaluate the long-term benefit of cervical cancer screening in a context of increasing risk of human papillomavirus infection.
methodsAd hoc-refined age-period-cohort models were applied to the last 50-year incidence data from Denmark, Finland, Norway and Sweden to project expected cervical cancer cases in a no-screening scenario.
resultsIn the absence of screening, projected incidence rates for 2006-2010 in Nordic countries would have been between 3 and 5 times higher than observed rates. Over 60,000 cases or between 41 and 49% of the expected cases of cervical cancer may have been prevented by the introduction of screening in the late 1960s and early 1970s.
conclusionsOur study suggests that screening programmes might have prevented a HPV-driven epidemic of cervical cancer in Nordic countries. According to extrapolations from cohort effects, cervical cancer incidence rates in the Nordic countries would have been otherwise comparable to the highest incidence rates currently detected in low-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.